Pfizer Inc. is developing a hybrid vaccine that combines its original shot with a formulation that shields against the highly transmissible omicron variant,...
Pfizer Inc. is developing a hybrid vaccine that combines its original shot with a formulation that shields against the highly transmissible omicron variant,...
Copenhagen: The World Health Organization (WHO) on Tuesday warned against treating COVID-19 as an endemic illness like flu, rather than as a pandemic,...
"My name is Kovid and I'm not a virus." Kovid Kapoor, from Bangalore, India, wrote that tweet in February 2020, right after the...
London: High levels of T-cells from common cold coronaviruses can provide protection against COVID-19, an Imperial College London study published on Monday has...
A study of patients infected with Covid-19 at a large hospital in the South African city where the first outbreak of the omicron...
The head of the World Health Organization (WHO) warned against describing the Omicron variant as "mild" amid a "tsunami of cases" overwhelming health...
GENEVA:More evidence is emerging that the Omicron coronavirus variant is affecting the upper respiratorytract, causing milder symptoms than previous variants, a World Health...
British scientists will be studying whether higher doses of a cheap and widely used steroid called dexamethasone could work better for patients with...
SYDNEY/ROME- Global COVID-19 infections hit a record high over the past seven-day period, Reuters data showed on Wednesday, as the Omicron variant raced...
India approvedMerck's COVID-19 pill and two more vaccines for emergency use as the world's second most populous country braces for a possible spike...
The U.S. Food and Drug Administration on Thursday authorized Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients, a day...
COVID-19 infections are more likely to trigger rare cardiovascular complications such as heart inflammation and irregular heartbeat than vaccines, a British study showed...
Johannesburg: Two doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70% protection against hospitalisation in South Africa in recent weeks, a major...
More than half a billion people globally were pushed into extreme poverty last year as they paid for health costs out of their...
Moderna Inc's messenger RNA-based experimental seasonal flu vaccine has produced robust antibodies against all four strains of the influenza virus in an early...
The U.S. Food and Drug Administration authorised booster shots of the COVID-19 vaccine from Pfizer/BioNTech for those aged 16 and 17, as public...
The Omicron variant of the coronavirus can partially evade the protection from Pfizer Inc and partner BioNTech's COVID-19 vaccine, Bloomberg News reported on...
The coronavirus pandemic has derailed the global campaign against malaria, increasing deaths from the mosquito-borne disease for the first time in three years....
